Abstract
Biotechnology Law ReportVol. 32, No. 4 Summaries of Recent EventsAssociation for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. (Supreme Court of the United States [No. 12-398])Published Online:9 Aug 2013https://doi.org/10.1089/blr.2013.9877AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byWastewater Monitoring Raises Privacy and Ethical ConsiderationsIEEE Transactions on Technology and Society, Vol. 2, No. 3WIPO’s Role in Procedural and Substantive Patent Law HarmonizationSSRN Electronic JournalLooking for therapeutic antibodies in next-generation sequencing repositories17 July 2019 | mAbs, Vol. 11, No. 7Genetic ConversionSSRN Electronic JournalThe Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the FrontlineSSRN Electronic JournalTell Me How It Ends: The Path to Nationalizing the U.S. Pharmaceutical IndustrySSRN Electronic JournalPharmaceutical Patent Wars, Reverse-Payment Settlements, and Their Anticompetitive Effects for ConsumersSSRN Electronic JournalPotential Implications of New Synthetic Biology and Genomic Research Trajectories on the International Treaty for Plant Genetic Resources for Food and AgricultureSSRN Electronic JournalThe Supreme Assimilation of Patent LawSSRN Electronic Journal, Vol. 124Intellectual Property: Law in ContextSSRN Electronic JournalThe Lehman Brothers Bankruptcy G: The Special Case of DerivativesSSRN Electronic JournalClimate Change, the International Intellectual Property Régime, and Disputes Under the TRIPSSSRN Electronic JournalJudicial Review of Economic Policies: Implications on Policy Formulation and ImplementationSSRN Electronic Journal Volume 32Issue 4Aug 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. (Supreme Court of the United States [No. 12-398]).Biotechnology Law Report.Aug 2013.262-270.http://doi.org/10.1089/blr.2013.9877Published in Volume: 32 Issue 4: August 9, 2013PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
